Cargando…
Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis
Metastasis accounts for more than 90% of cancer related mortality, thus the most pressing need in the field of oncology today is the ability to accurately predict future onset of metastatic disease, ideally at the time of initial diagnosis. As opposed to current practice, what would be desirable is...
Autores principales: | Ray, Tania, Ryusaki, Terry, Ray, Partha S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446626/ https://www.ncbi.nlm.nih.gov/pubmed/34540690 http://dx.doi.org/10.3389/fonc.2021.721959 |
Ejemplares similares
-
Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
por: Li, Dandan, et al.
Publicado: (2023) -
RNA-seq Analysis of Wild-Type vs. FOXC2-Deficient Melanoma Cells Reveals a Role for the FOXC2 Transcription Factor in the Regulation of Multiple Oncogenic Pathways
por: Hargadon, Kristian M., et al.
Publicado: (2020) -
EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?
por: Ansieau, Stéphane, et al.
Publicado: (2014) -
Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer
por: Huang, Mao-Sen, et al.
Publicado: (2022) -
The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis
por: Liu, Hao, et al.
Publicado: (2021)